Bio-Rad Laboratories, Inc. (NYSE: BIO) announced the FDA clearance of two new multiplex infectious disease serology panels for use on ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE